Pacific Biosciences of California, Inc.

PACB ·Technology, Scientific & Technical Instruments, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010 FY2009
Revenue $1.7M $135.0K
Cost of Revenue
Gross Profit $1.7M $135.0K
Gross Margin 100.0% 100.0%
Operating Expenses
Research & Development $111.8M $75.9M
SG&A Expense $30.1M $12.3M
Operating Income
Operating Margin
Interest Expense
Pretax Income
Income Tax Expense
Net Income $-140.2M $-87.7M
Net Margin -8,373.1% -64,965.2%
EPS (Basic) $-14.10 $-173.03
EPS (Diluted) $-14.10 $-173.03
Shares Outstanding (Basic) 52.9M
Shares Outstanding (Diluted) 52.9M
Dividends Per Share
← Newer Page 3 of 3 Older →